Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P17931 (
galectin-3
)
2,860
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
C4.4A is a member of the Ly6 family, with low homology to uPAR. It has been detected mainly on metastasizing carcinoma cells and proposed to be involved in wound healing. So far, C4.4A has been observed as an orphan receptor, and its functional activity has not been explored. Using recombinant rat C4.4A (rrC4.4A) made in a eukaryotic expression system, we demonstrate by immunohistology that C4.4A ligands are strongly expressed in tissues adjacent to squamous epithelia of, e.g., tongue and esophagus, the expression pattern partly overlapping with laminin (LN) and complementing the C4.4A expression that is found predominantly on the basal layers of squamous epithelium. ELISA screening of several components of the extracellular matrix revealed selective binding of rrC4.4A to
LN1
and LN5 and that transfection of the BSp73AS tumor line with C4.4A cDNA (BSp73AS-1B1) promoted
LN1
and LN5 binding. Binding of BSp73AS-1B1 to LN5 and, less markedly,
LN1
induced spreading, lamellipodia formation and migration. C4.4A also associates with
galectin-3
in nontransformed tissues and tumor lines. There is evidence that the association of C4.4A with
galectin-3
influences LN adhesion. C4.4A was described originally as a metastasis-associated molecule. Our findings that
LN1
and LN5 are C4.4A ligands, that
galectin-3
associates with C4.4A and that C4.4A ligand binding confers a migratory phenotype are well in line with the supposed metastasis association.
...
PMID:Ly6 family member C4.4A binds laminins 1 and 5, associates with galectin-3 and supports cell migration. 1572 93